Article
Methylated genes as potential biomarkers in prostate cancer
8 Jan 2010
Abstract excerpt
Prostate cancer is the most common malignancy of the urogenital tract. Although controversial, prostate-specific antigen (PSA) testing is widely used for screening and follow-up of prostate cancer, but because of its limited specificity and sensitivity, PSA is not an ideal test. We currently lack the necessary tools to differentiate between latent disease with little likelihood of clinical manifestation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
